Ketamine is seeing a resurgence in its medical application, particularly in treating treatment-resistant depression (TRD).
The groundbreaking approval of a ketamine-based nasal spray by the FDA on March 5, 2019, marked a major advancement in the treatment of major depression.
Massachusetts General Brigham (MGB) researchers made a significant discovery in the treatment of severe depression.
A common question that arises is, "Is ketamine an opioid?" The straightforward answer is no, ketamine is not an opioid.
Side effects may include: feelings of dissociation or being detached from the body, dizziness or lightheadedness, nausea and vomiting, elevated blood pressure, blurred vision & slurred speech.
Ketamine is a versatile medication with several uses in modern medicine, primarily known for its anesthetic properties but increasingly recognized for its potential in treating certain mental health conditions.